- Montpellier Medical School, Montpellier, France - MS in Immunology
- Montpellier Medical School - MD
- University of Wisconsin School of Medicine and Public Health - Postdoctoral Research Fellowship, Transplant Medicine
- Wayne State University, Detroit, Michigan - Residency in Internal Medicine
- University of Wisconsin Hospital and Clinics - Fellowship in Nephrology
Dr. Arjang Djamali is a faculty member and chief of the Division of Nephrology within the Department of Medicine. As a transplant nephrologist, Dr. Djamali seeks to improve graft and patient survival outcomes in kidney transplant patients. He is a Fellow of the American Society of Nephrology and a member of the American Society of Transplantation, and his work has been funded by the National Institutes of Health, industry, and foundations. Dr. Djamali and has been selected for the Best Doctors in America® list and Top Docs in Madison list multiple times. He serves as a grant reviewer on multiple panels for the National Institutes of Health and for the Veterans Affairs Hospital NEPH Study Section. He frequently serves as session chair for annual meetings of both the American Society of Nephrology and the American Society of Transplantation. Dr. Djamali has taught nephrology topics to students in MD programs, provides classroom and clinical instruction to residents and fellows, and serves as a research mentor to undergraduate students, graduate students, trainees, and junior faculty members.
Dr. Djamali’s clinical interests include nephrology, transplant medicine, and the medical management of transplant patients.
View Dr. Arjang Djamali’s Publications on NCBI My Bibliography
Dr. Djamali’s research program broadly focuses on understanding the progression of transplant kidney diseases and assessing the mechanisms of graft injury to ultimately improve graft and patient outcomes. Dr. Djamali has a broad background in immunology and transplant medicine, with specific training and expertise in key research areas including immunosuppression, oxidative stress, allograft fibrosis, and antibody mediated processes. To this end, his research laboratory as developed animal models of acute and chronic injury including unilateral ureteral obstruction (UUO), ischemia reperfusion injury (IRI), chronic calcineurin inhibitor (CNI) nephrotoxicity, and antibody-mediated rejection (ABMR) and he has conducted numerous clinical studies and trials in these areas.